We are proud to share that our practice has been selected to present at ENDO 2026, the Endocrine Society’s annual meeting in Chicago — the largest gathering of endocrinologists in the world.
Our presentation, “Single-session trans-isthmic radiofrequency ablation for benign thyroid nodules: a 24-month single-practice experience,” reviews outcomes in 118 consecutive patients treated in our own office with ultrasound-guided radiofrequency ablation (RFA). RFA is a minimally invasive, in-office technique that shrinks benign thyroid nodules and allows many patients to avoid thyroid surgery.
Being invited to present this work reflects our commitment to advancing thyroid care and to offering San Diego patients procedures that remain available at only a handful of centers nationwide. We were among the first practices in San Diego to offer ultrasound-guided thyroid RFA, and we continue to build one of the region’s largest single-practice experiences with the technique.
If you have a thyroid nodule and would like to learn whether RFA is an option for you, we welcome you to contact our office.
